Ha Kung Wong: FDA and FTC Cooperation to Address Anticompetitive Behavior
September 4th 2018Ha Kung Wong, JD, partner at Fitzpatrick, Cella, Harper and Scinto, discusses how the FDA and Federal Trade Commission (FTC) might work together to address anticompetitive behavior in the biosimilars marketplace.
Vivian Bykerk, MD: Biologic Therapies versus Conventional Disease-Modifying Anti-Rheumatic Drugs
July 30th 2018Vivian Bykerk, MD, associate attending rheumatologist at the Hospital for Special Surgery, associate professor of medicine at Weill Cornell Medical College, provides an overview of what patients should know about biologic therapies versus conventional disease-modifying anti-rheumatic drugs.